MS Trial Alert: Investigators in Ohio Recruiting 24 People for Study of Autologous Mesenchymal Stem Cell Transplantation

Summary: Investigators in Ohio are recruiting 24 people with relapsing forms of MS for a study of the safety and tolerability of transplanting one’s own mesenchymal stem cells (derived from bone marrow). The study is being conducted at Cleveland Clinic Mellen MS Center, University Hospitals Case Medical Center, and the National Center for Stem Cell and Regenerative Medicine, all in Cleveland. This study is supported by the Congressionally Directed Medical Research Programs, a program funded through the Defense Department, thanks in large part to the tireless work of MS activists across the country who helped to secure the funding. Please note: This study involves numerous visits to the study site.

Rationale: There are many types of stem cells, and varying degrees of research and knowledge about different types of stem cells and their potential usefulness for treating MS. At present, there has been no proven therapy for MS that uses stem cells. Read more about stem cells in MS.